Source link : https://www.newshealth.biz/health-news/high-dose-vitamin-d-linked-to-lower-disease-activity-in-cis/
COPENHAGEN, Denmark — High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduces evidence of disease activity in patients with clinically isolated syndrome (CIS), results of a randomized, controlled trial suggest. In addition, cholecalciferol had a favorable safety profile and was well tolerated. “These data support high-dose vitamin D supplementation in early MS and make vitamin D […]
Author : News Health
Publish date : 2024-09-20 11:21:02
Copyright for syndicated content belongs to the linked Source.
